Published in EMBO J on January 01, 1982
Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci U S A (1984) 7.77
Foot-and-mouth disease. Clin Microbiol Rev (2004) 4.34
Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J (1986) 4.32
Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med (1987) 4.21
The duck hepatitis B virus pre-C region encodes a signal sequence which is essential for synthesis and secretion of processed core proteins but not for virus formation. J Virol (1987) 3.39
Structure of the FMDV translation initiation site and of the structural proteins. Nucleic Acids Res (1983) 2.58
Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J Virol (1989) 2.27
Identification of the human papilloma virus-1a E4 gene products. EMBO J (1986) 2.21
Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination. J Virol (1987) 2.02
Localization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1. Proc Natl Acad Sci U S A (1983) 1.94
Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies. Proc Natl Acad Sci U S A (1985) 1.79
Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus. Proc Natl Acad Sci U S A (1989) 1.71
Comparison of the amino acid sequence of the major immunogen from three serotypes of foot and mouth disease virus. Nucleic Acids Res (1982) 1.66
Primary structure and nuclear localization of a murine homeodomain protein. Proc Natl Acad Sci U S A (1987) 1.63
A poliovirus type 1 neutralization epitope is located within amino acid residues 93 to 104 of viral capsid polypeptide VP1. EMBO J (1983) 1.59
Expression of the P-protein of the human hepatitis B virus in a vaccinia virus system and detection of the nucleocapsid-associated P-gene product by radiolabelling at newly introduced phosphorylation sites. Nucleic Acids Res (1992) 1.50
Evolution subverting essentiality: dispensability of the cell attachment Arg-Gly-Asp motif in multiply passaged foot-and-mouth disease virus. Proc Natl Acad Sci U S A (1997) 1.37
A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J Virol (1997) 1.36
Unique amino acid substitutions in the capsid proteins of foot-and-mouth disease virus from a persistent infection in cell culture. J Virol (1990) 1.35
The molecular basis of the antigenic variation of foot-and-mouth disease virus. EMBO J (1983) 1.33
Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage. J Virol (2000) 1.32
Analysis of neutralizing epitopes on foot-and-mouth disease virus. J Virol (1988) 1.32
Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin. Proc Natl Acad Sci U S A (1983) 1.26
Comparison of the major antigenic determinants of different serotypes of foot-and-mouth disease virus. J Virol (1983) 1.24
Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. J Virol (1994) 1.23
VP1 of serotype C foot-and-mouth disease viruses: long-term conservation of sequences. J Virol (1988) 1.22
Sequence variation in the gene for the immunogenic capsid protein VP1 of foot-and-mouth disease virus type A. Proc Natl Acad Sci U S A (1985) 1.19
Specificity of the VP1 GH loop of Foot-and-Mouth Disease virus for alphav integrins. J Virol (2006) 1.16
Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides. Immunology (1990) 1.13
Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus. J Virol (1994) 1.07
Point mutations within the betaG-betaH loop of foot-and-mouth disease virus O1K affect virus attachment to target cells. J Virol (1997) 1.06
Gene encoding capsid protein VP1 of foot-and-mouth disease virus: a quasispecies model of molecular evolution. Proc Natl Acad Sci U S A (1988) 1.05
Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus. Immunology (1991) 1.04
Inhibition of DNA binding of purified p55v-myc in vitro by antibodies against bacterially expressed myc protein and a synthetic peptide. EMBO J (1984) 0.98
Identification of foot-and-mouth disease virus-specific linear B-cell epitopes to differentiate between infected and vaccinated cattle. J Virol (2003) 0.97
Molecular characterization of the P1-like adhesin gene from Mycoplasma pirum. J Bacteriol (1994) 0.97
Detection in vivo of a new gene product (gene III) of cauliflower mosaic virus. Proc Natl Acad Sci U S A (1984) 0.97
Antibodies against synthetic peptides of herpes simplex virus type 1 glycoprotein D and their capability to neutralize viral infectivity in vitro. J Virol (1988) 0.93
Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus. J Virol (1990) 0.93
A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodies. Proc Natl Acad Sci U S A (1997) 0.91
Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle. Immunology (1992) 0.88
Research in advance for FMD novel vaccines. Virol J (2011) 0.86
Antibodies against synthetic oligopeptides allow identification of the mRNA-maturase encoded by the second intron of the yeast cob-box gene. EMBO J (1984) 0.86
New aspects of vaccine development. Clin Exp Immunol (1985) 0.83
Proteomic approach for characterization of immunodominant membrane-associated 30- to 36-kiloDalton fraction antigens of Leishmania infantum promastigotes, reacting with sera from Mediterranean visceral leishmaniasis patients. Clin Diagn Lab Immunol (2005) 0.82
Genome variation in the SAT types of foot-and-mouth disease viruses prevalent in buffalo (Syncerus caffer) in the Kruger National Park and other regions of southern Africa, 1986-93. Epidemiol Infect (1995) 0.81
Functional characterization of fingers subdomain-specific monoclonal antibodies inhibiting the hepatitis C virus RNA-dependent RNA polymerase. J Biol Chem (2008) 0.81
Analysis of immune responses in the sheep to synthetic peptides of foot-and-mouth disease virus using ovine polyclonal and monoclonal antibodies. Immunology (1990) 0.80
Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine. Clin Vaccine Immunol (2010) 0.80
Human Memory B Cells Producing Potent Cross-Neutralizing Antibodies against Human Parechovirus: Implications for Prevalence, Treatment, and Diagnosis. J Virol (2015) 0.79
Unprocessed foot-and-mouth disease virus capsid precursor displays discontinuous epitopes involved in viral neutralization. J Virol (1994) 0.79
A high proportion of anti-peptide antibodies recognize foot-and-mouth disease virus particles. Immunology (1988) 0.78
Towards assignment of secondary structures by anti-peptide antibodies. Specificity of the immune response to a beta-turn. EMBO J (1985) 0.78
Determining the epitope dominance on the capsid of a serotype SAT2 foot-and-mouth disease virus by mutational analyses. J Virol (2014) 0.77
Use of a baculovirus-expressed structural protein for the detection of antibodies to foot-and-mouth disease virus type A by a blocking enzyme-linked immunosorbent assay. Clin Vaccine Immunol (2009) 0.77
Foot-and-mouth disease: overview of motives of disease spread and efficacy of available vaccines. J Anim Sci Technol (2015) 0.77
Structural and immunological characterization of Friend murine leukaemia virus glycopolypeptide using synthetic oligopeptides. EMBO J (1984) 0.75
Monoclonal antibodies specific for the C-terminus of the laminin B2 subunit. Evidence for glycosylation differences between murine and human laminin. Biochem J (1991) 0.75
Immunogenicity of two FMDV nonameric peptides encapsulated in liposomes in mice and the protective efficacy in guinea pigs. PLoS One (2013) 0.75
Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol (1978) 33.47
Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A (1981) 32.98
Prediction of protein conformation. Biochemistry (1974) 20.51
Enzyme immunoassays in diagnostic medicine. Theory and practice. Bull World Health Organ (1976) 12.01
Immunogenic structure of the influenza virus hemagglutinin. Cell (1982) 8.93
Use of helical wheels to represent the structures of proteins and to identify segments with helical potential. Biophys J (1967) 8.10
Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science (1981) 5.66
Molecular mechanisms of variation in influenza viruses. Nature (1982) 5.54
Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc Natl Acad Sci U S A (1981) 4.26
Antibodies specific for the carboxy- and amino-terminal regions of simian virus 40 large tumor antigen. Proc Natl Acad Sci U S A (1980) 4.04
Prediction of chain turns in globular proteins on a hydrophobic basis. Nature (1978) 3.61
Immunogenicity of trinitrophenyl-hemocyanin: production of primary and secondary anti-hapten precipitins. J Immunol (1966) 3.56
Algorithms for prediction of alpha-helical and beta-structural regions in globular proteins. J Mol Biol (1974) 3.19
Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature (1982) 3.01
Location and characterization of the antigenic portion of the FMDV immunizing protein. J Gen Virol (1982) 2.62
Nucleotide sequence and corresponding amino acid sequence of the gene for the major antigen of foot and mouth disease virus. Nucleic Acids Res (1981) 2.61
Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide. Proc Natl Acad Sci U S A (1982) 2.52
Antibodies specific for the polyoma virus middle-size tumor antigen. Proc Natl Acad Sci U S A (1981) 2.02
Crystallographic refinement of rubredoxin at 1 x 2 A degrees resolution. J Mol Biol (1980) 1.85
Anti-influenza response achieved by immunization with a synthetic conjugate. Proc Natl Acad Sci U S A (1982) 1.85
The nucleotide sequence of cDNA coding for the structural proteins of foot-and-mouth disease virus. Gene (1982) 1.82
Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. J Immunol (1975) 1.76
Antibodies to chemically synthesized peptides predicted from DNA sequences as probes of gene expression. Cell (1981) 1.52
Preparation and properties of an artificial antigen immunologically related to tobacco mosaic virus. Biochim Biophys Acta (1963) 1.37
Antiviral effect on MS-2 coliphage obtained with a synthetic antigen. Proc Natl Acad Sci U S A (1976) 1.37
Triplet information in helix prediction applied to the analysis of super-secondary structures. J Mol Biol (1977) 1.34
Surface structure of foot-and-mouth disease virus. J Gen Virol (1969) 1.25
[Relation of the secondary structure of globular proteins to their primary structure]. Biofizika (1970) 0.92
Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5. Gene (1982) 13.62
Hepatitis B virus genes and their expression in E. coli. Nature (1979) 10.83
A new sensitive method for qualitative and quantitative assay of neomycin phosphotransferase in crude cell extracts. Gene (1984) 7.36
Nucleotide sequence of bacteriophage fd DNA. Nucleic Acids Res (1978) 7.25
Nucleotide sequence of an RNA polymerase binding site from the DNA of bacteriophage fd. Proc Natl Acad Sci U S A (1975) 7.14
Structural analysis of Tn5. Cold Spring Harb Symp Quant Biol (1981) 6.16
High-level hepatitis B virus replication in transgenic mice. J Virol (1995) 5.81
A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO J (1990) 5.74
Nucleotide sequence of the origin of replication of the Escherichia coli K-12 chromosome. Proc Natl Acad Sci U S A (1979) 5.31
The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J Virol (1990) 5.19
Signals regulating hepatitis B surface antigen transcription. Nature (1983) 5.02
Interaction of RNA polymerase with promoters from bacteriophage fd. Eur J Biochem (1977) 4.94
Penicillinase from Bacillus licheniformis: nucleotide sequence of the gene and implications for the biosynthesis of a secretory protein in a Gram-positive bacterium. Nucleic Acids Res (1981) 4.94
Comparative sequence analysis of duck and human hepatitis B virus genomes. J Med Virol (1985) 4.68
Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol (1990) 4.57
Replication strategy of human hepatitis B virus. J Virol (1987) 4.42
Transcripts and the putative RNA pregenome of duck hepatitis B virus: implications for reverse transcription. Cell (1985) 4.41
Molecular architecture and electrostatic properties of a bacterial porin. Science (1991) 4.27
Structure of the outer membrane protein A transmembrane domain. Nat Struct Biol (1998) 4.06
Characterization of foot-and-mouth disease virus gene products with antisera against bacterially synthesized fusion proteins. J Virol (1986) 3.89
Nucleotide sequence and genome organization of foot-and-mouth disease virus. Nucleic Acids Res (1984) 3.81
Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J (1992) 3.78
Conversion of bacteriophage fd into an efficient single-stranded DNA vector system. Mol Gen Genet (1980) 3.57
The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription. EMBO J (1988) 3.52
Structure of the orgin of DNA replication of bacteriophage fd. Proc Natl Acad Sci U S A (1978) 3.52
Hepatitis B virus transcription in the infected liver. EMBO J (1984) 3.44
The ras-related YPT1 gene product in yeast: a GTP-binding protein that might be involved in microtubule organization. Cell (1986) 3.40
The duck hepatitis B virus pre-C region encodes a signal sequence which is essential for synthesis and secretion of processed core proteins but not for virus formation. J Virol (1987) 3.39
Structure and function of a squalene cyclase. Science (1997) 3.38
Synthesis and encapsidation of duck hepatitis B virus reverse transcriptase do not require formation of core-polymerase fusion proteins. Cell (1989) 3.31
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med (1995) 3.20
Transposition of a DNA sequence determining kanamycin resistance into the single-stranded genome of bacteriophage fd. Mol Gen Genet (1978) 3.19
Structure of the complex between adenylate kinase from Escherichia coli and the inhibitor Ap5A refined at 1.9 A resolution. A model for a catalytic transition state. J Mol Biol (1992) 3.17
Function of DNA polymerase 3 in DNA replication. Nat New Biol (1971) 3.10
Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line. EMBO J (1987) 3.09
Expression and replication of the hepatitis B virus genome under foreign promoter control. Nucleic Acids Res (1987) 2.94
Adenine nucleotide translocation of mitochondria. 1. Specificity and control. Eur J Biochem (1968) 2.91
Initiation of deoxyribonucleic acid synthesis. VII. A unique location of the gap in the M13 replicative duplex synthesized in vitro. J Biol Chem (1974) 2.85
Cloned HBV DNA causes hepatitis in chimpanzees. Nature (1982) 2.80
Affinity chromatography of DNA-binding enzymes on single-stranded DNA-agarose columns. Eur J Biochem (1972) 2.76
Structure of porin refined at 1.8 A resolution. J Mol Biol (1992) 2.71
Structure of the DNA of bacteriophage fd. II. Isolation and characterization of a DNA fraction with double strand-like properties. J Mol Biol (1969) 2.71
Substrate positions and induced-fit in crystalline adenylate kinase. J Mol Biol (1977) 2.69
Deoxyribonucleic acid replication in vitro. J Mol Biol (1972) 2.64
Nucleotide sequence and corresponding amino acid sequence of the gene for the major antigen of foot and mouth disease virus. Nucleic Acids Res (1981) 2.61
Refined structure of glutathione reductase at 1.54 A resolution. J Mol Biol (1987) 2.60
Adenylate kinase motions during catalysis: an energetic counterweight balancing substrate binding. Structure (1996) 2.53
Biochemical and immunological characterization of the duck hepatitis B virus envelope proteins. J Virol (1987) 2.50
Single RNA polymerase binding site isolated. Nat New Biol (1972) 2.47
The duck hepatitis B virus core protein contains a highly phosphorylated C terminus that is essential for replication but not for RNA packaging. J Virol (1989) 2.47
Mapping and characterization of promoters in bacteriophages fd, f1 and m13. J Mol Biol (1975) 2.46
Hepatitis B virus replication. Trends Microbiol (1993) 2.41
High-resolution structure of the OmpA membrane domain. J Mol Biol (2000) 2.40
Isolation and characterization of thermosensitive Escherichia coli mutants defective in deoxyribonucleic acid replication. J Bacteriol (1973) 2.38
The structure of the outer membrane protein OmpX from Escherichia coli reveals possible mechanisms of virulence. Structure (1999) 2.36
Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J Virol (1989) 2.27
Translational inactivation of RNA function: discrimination against a subset of genomic transcripts during HBV nucleocapsid assembly. Cell (1990) 2.26
Infectious hepatitis B virus from cloned DNA of known nucleotide sequence. Proc Natl Acad Sci U S A (1985) 2.20
An RNA transcribed from DNA at the origin of phage fd single strand to replicative form conversion. Proc Natl Acad Sci U S A (1978) 2.19
[Correlation of the unspecific permeable mitochondrial space with the "intermembrane space"]. Eur J Biochem (1968) 2.18
Movie of the structural changes during a catalytic cycle of nucleoside monophosphate kinases. Structure (1995) 2.17
The intergenic region and the origins for filamentous phage DNA replication. Cold Spring Harb Symp Quant Biol (1979) 2.15
Cloning of cDNA of major antigen of foot and mouth disease virus and expression in E. coli. Nature (1981) 2.14
Protein fusions with the kanamycin resistance gene from transposon Tn5. EMBO J (1984) 2.13
DNA-binding activity is associated with purified myb proteins from AMV and E26 viruses and is temperature-sensitive for E26 ts mutants. Cell (1985) 2.11
Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription. J Virol (1994) 2.10
Cleavage site of bacteriophage fd gene II-protein in the origin of viral strand replication. Nature (1979) 2.09
Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor. J Virol (1993) 2.05
A tandem repeat gene in a picornavirus. Nucleic Acids Res (1982) 2.03
Putative reverse transcriptase intermediates of human hepatitis B virus in primary liver carcinomas. Science (1986) 2.00
Unspecific permeation and specific exchange of adenine nucleotides in liver mitochondria. Biochim Biophys Acta (1965) 2.00
Substrate binding and catalysis by glutathione reductase as derived from refined enzyme: substrate crystal structures at 2 A resolution. J Mol Biol (1989) 1.98
The duck hepatitis B virus DNA polymerase is tightly associated with the viral core structure and unable to switch to an exogenous template. Virology (1988) 1.94
The three-dimensional structure of porin from Rhodobacter capsulatus at 3 A resolution. FEBS Lett (1990) 1.92
The topology of DNA from the small filamentous bacteriophage fd. J Mol Biol (1966) 1.91
The secretory core protein of human hepatitis B virus is expressed on the cell surface. J Virol (1989) 1.91
Refined structure of the porin from Rhodopseudomonas blastica. Comparison with the porin from Rhodobacter capsulatus. J Mol Biol (1994) 1.89
Origin of replication, oriC, of the Escherichia coli K12 chromosome: nucleotide sequence. Cold Spring Harb Symp Quant Biol (1979) 1.89
Three dimensional structure of adenyl kinase. Nature (1974) 1.88
Expression of hepatitis B antigens with a simian virus 40 vector. J Virol (1984) 1.80
Comparison of the three-dimensional protein and nucleotide structure of the FAD-binding domain of p-hydroxybenzoate hydroxylase with the FAD- as well as NADPH-binding domains of glutathione reductase. J Mol Biol (1983) 1.76
Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken. Proc Natl Acad Sci U S A (1996) 1.75
Adenine nucleotide translocation of mitochondria. Kinetics of the adenine nucleotide exchange. Eur J Biochem (1969) 1.75
Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J Gen Virol (1993) 1.73
Isoprenoid biosynthesis: manifold chemistry catalyzed by similar enzymes. Structure (1998) 1.71
Regeneration of hydra from reaggregated cells. Nat New Biol (1972) 1.69
The structure of porin from Rhodobacter capsulatus at 1.8 A resolution. FEBS Lett (1991) 1.66
Hepatitis B virus replication--an update. J Viral Hepat (1996) 1.66
Structure of the membrane channel porin from Rhodopseudomonas blastica at 2.0 A resolution. Protein Sci (1994) 1.65
High-resolution structures of adenylate kinase from yeast ligated with inhibitor Ap5A, showing the pathway of phosphoryl transfer. Protein Sci (1995) 1.64
Production of infectious duck hepatitis B virus in a human hepatoma cell line. J Virol (1988) 1.62
The structure of the flavoenzyme glutathione reductase. Nature (1978) 1.61
A new approach to the sequence analysis of DNA. FEBS Lett (1972) 1.60
A DNA fragment from the origin of single-strand to double-strand DNA replication of bacteriophage fd. Proc Natl Acad Sci U S A (1976) 1.58
Bunyaviruses and Bunyaviridae. Intervirology (1976) 1.58
Detection of an element of the SV40 late promoter in vectors used for expression studies in COS cells. EMBO J (1983) 1.57